Vaxart (VXRT) Capital Expenditures (2010 - 2026)
Vaxart's Capital Expenditures came in at $35,000 for Q2 2026, compared with -$103,000 a year earlier and down 92.2% from the prior quarter.
Powered by 
Analysis
Vaxart (VXRT) Capital Expenditures (2010 - 2026) Analysis & Trends
Over the trailing twelve months to Jun 30, 2026, Vaxart reported Capital Expenditures of $601,000, up 651.3% year-over-year; for FY2025, it came in at $145,000, down 73.8% from FY2024.
- Capital Expenditures has declined in each of the last three years, with a five-year compound annual growth rate of -34.7% (FY2020 to FY2025).
- Going back by year, Capital Expenditures was $554,000 in FY2024 (-70.4%), $1.87 million in FY2023 (-80.5%), $9.6 million in FY2022 (+86.2%) and $5.16 million in FY2021 (+321.7%).
- The five-year range for quarterly Capital Expenditures is -$104,000 (Q4 2023) to $3.9 million (Q4 2022).
- Year-over-year, Capital Expenditures increased in 1 of the last four quarters, with growth averaging 12.3%.
- The fastest year-over-year change in Capital Expenditures over five years came in Q3 2021 (growth of 329.9%), and the weakest in Q4 2025 (a decline of 97.7%).
- Business Quant data shows VXRT's Capital Expenditures at $448,000 (Q1 2026), $1,000 (Q4 2025) and $117,000 (Q3 2025) in the three quarters before Q2 2026.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Capex (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,348.13 Bn | 1,321.74 Bn | 20.46 Bn | 3.18 Bn |
| 2 | Johnson & Johnson | 675.90 Bn | 595.76 Bn | 17.30 Bn | 1.36 Bn |
| 3 | AbbVie | 519.45 Bn | 487.50 Bn | 13.12 Bn | 301.00 Mn |
| 4 | Merck | 364.95 Bn | 327.95 Bn | 13.19 Bn | 1.04 Bn |
| 5 | Novartis Ag | 311.58 Bn | 285.16 Bn | - | - |
| 6 | Astrazeneca | 289.34 Bn | 262.94 Bn | 13.26 Bn | -3.30 Bn |
| 7 | Amgen | 251.64 Bn | 203.30 Bn | 7.58 Bn | 587.00 Mn |
| 8 | Gilead Sciences | 212.05 Bn | 187.07 Bn | 6.73 Bn | 237.00 Mn |
| 9 | Pfizer | 167.35 Bn | 115.00 Bn | 12.56 Bn | 573.00 Mn |
| 10 | Vaxart | 87.73 Mn | 22.23 Mn | - | 371,000.00 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Sep 30, 2026 | 371,000.00 |
| Jun 30, 2026 | 35,000.00 |
| Mar 31, 2026 | 448,000.00 |
| Dec 31, 2025 | 1,000.00 |
| Sep 30, 2025 | 117,000.00 |
| Jun 30, 2025 | -103,000.00 |
| Mar 31, 2025 | 130,000.00 |
| Dec 31, 2024 | 44,000.00 |
| Sep 30, 2024 | 9,000.00 |
| Jun 30, 2024 | 370,000.00 |
| Mar 31, 2024 | 131,000.00 |
| Dec 31, 2023 | -104,000.00 |
| Sep 30, 2023 | 282,000.00 |
| Jun 30, 2023 | 454,000.00 |
| Mar 31, 2023 | 1.24 Mn |
| Dec 31, 2022 | 3.90 Mn |
| Sep 30, 2022 | 2.03 Mn |
| Jun 30, 2022 | 2.33 Mn |
| Mar 31, 2022 | 1.35 Mn |
| Dec 31, 2021 | 1.02 Mn |
API Access
Vaxart Capital Expenditures API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=capital-expenditures&ticker=VXRT&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "capital-expenditures", "ticker": "VXRT", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=capital-expenditures&ticker=VXRT&period=max&api_key=YOUR_API_KEY");
const data = await res.json();